stop_circleTerminated/Withdrawn

Bacterial Infections

Bayer Identifier:
Trial_0575
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
IV and oral ciprofloxacin in the treatment of selected paediatric infections

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

3 - 14 Years

Trial summary

Enrollment Goal
59
Trial Dates
February 1997 - August 1999
Phase
Phase 2
Could I Receive a placebo
N/A
Products
Cipro (Ciprofloxacin, BAYQ3939)
Accepts Healthy Volunteer
N/A

Trial design

A prospective, open, multi-centre study to determine the safety of IV and oral ciprofloxacin in the treatment of selected paediatric infections
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.